FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
Status:
Completed
Trial end date:
2014-05-23
Target enrollment:
Participant gender:
Summary
This randomized, double masked, multi-center study is being conducted to support the safety
and efficacy of FST-100 for the treatment of acute adenoviral conjunctivitis.